[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, teplizumab has shown promise for diabetes prevention. Document [0] states that teplizumab could delay the development of diabetes in family members of type I diabetics showing signs of progression towards diabetes. Document [1] mentions that teplizumab has been shown to preserve \u03b2 cell function in patients. Document [4] also highlights the promising results of anti-CD3 monoclonal antibodies, including teplizumab, in preventing type 1 diabetes. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]